[PDF][PDF] Investigating the Pharmacological Mechanisms of SheXiang XinTongNing Against Coronary Heart Disease Based on Network Pharmacology and Experimental …

L Jia, G Cao, J Li, L Gan, J Li, X Lan… - … | www. frontiersin. org, 2021 - pure.qub.ac.uk
Cardiovascular disease, as a leading cause of deaths worldwide, has led to 17.3 million
deaths globally (Townsend et al., 2016). Most cases of cardiovascular diseases-induced …

[HTML][HTML] Investigating the pharmacological mechanisms of SheXiang XinTongNing against coronary heart disease based on network pharmacology and experimental …

L Jia, G Cao, J Li, L Gan, J Li, X Lan, Z Meng… - Frontiers in …, 2021 - frontiersin.org
SheXiang XinTongNing (XTN), which is composed of six traditional Chinese herbs, is a
commercially available Chinese patent medicine that has been widely used as the treatment …

[HTML][HTML] Network pharmacology-based analysis on the molecular biological mechanisms of Xin Hui Tong Formula in coronary heart disease treatment

WU Hua-Ying, Z Chen, W Zhao-Hua, Z Shi-Ying… - Digital Chinese …, 2019 - Elsevier
Objective To investigate the potential molecular mechanism of Xin Hui Tong Formula (XHTF)
in the treatment of coronary heart disease (CHD) by using network pharmacology and …

Mechanism of Xinnaining Capsule in treating coronary heart disease based on network pharmacology

LI Jing, Z Ying, MEI Jun, Z Ping… - Beijing Journal of …, 2023 - bjtcm.net
Objective To study on the mechanism of Xinnaoning Capsule in treating coronary
atherosclerotic heart disease (CHD) based on network pharmacology. Methods Searching …

Network Pharmacology and Molecular Docking‐Based Analysis on Bioactive Anticoronary Heart Disease Compounds in Trichosanthes kirilowii Maxim and Bulbus …

YD Yu, WJ Hou, J Zhang, YT Xue… - … and Alternative Medicine, 2021 - Wiley Online Library
Trichosanthes kirilowii Maxim. and Bulbus allii Macrostemi are the components of Gualou
Xiebai decoction (GLXB), a commonly used herbal combination for the treatment of coronary …

Exploring the Potential Mechanism of Guanxinkang Decoction in the Treatment of Atherosclerosis Based on Bioinformatics and Network Pharmacology

J Wang, X Feng, Y Zhang, M Du, S Li, X Chang… - Available at SSRN … - papers.ssrn.com
Background: Guanxinkang Decoction (GXK) is a Chinese herbal formula commonly used to
treat atherosclerosis (AS). However, its active ingredients and in-depth mechanism require …

[HTML][HTML] Network pharmacology-based exploration of the mechanism of Guanxinning tablet for the treatment of stable coronary artery disease

S Sheng, QN Yang, HN Zhu… - World Journal of Traditional …, 2021 - journals.lww.com
Objective: Network pharmacology was utilized to explore the mechanism of Guanxinning
(GXN) tablet for the treatment of stable coronary artery disease (SCAD). Materials and …

[HTML][HTML] Mechanism of Tao Hong Decoction in the treatment of atherosclerosis based on network pharmacology and experimental validation

SJ Li, P Liu, X Feng, M Du, Y Zhang… - Frontiers in …, 2023 - frontiersin.org
Background: Atherosclerosis (AS) has long been recognized as a cardiovascular disease
and stroke risk factor. A well-known traditional Chinese medicine prescription, Tao Hong …

[HTML][HTML] Integrated network pharmacology and metabonomics to reveal the myocardial protection effect of Huang-Lian-Jie-Du-Tang on myocardial ischemia

L Li, W Dai, W Li, Y Zhang, Y Wu, C Guan… - Frontiers in …, 2021 - frontiersin.org
Myocardial ischemia (MI) is one of the most common cardiovascular diseases with high
incidence and mortality. Huang-Lian-Jie-Du-Tang (HLJDT) is a classic traditional Chinese …

[HTML][HTML] Yindanxinnaotong, a Chinese compound medicine, synergistically attenuatesatherosclerosis progress

L Cheng, G Pan, X Zhang, J Wang, W Wang, J Zhang… - Scientific reports, 2015 - nature.com
Yindanxinnaotong (YD), a traditional Chinese medicine, has been introduced toclinical
medicine for more than a decade, while its pharmacological properties arestill not to be well …